; Contraceptive Devices Market Size, Analysis, Forecast, 2031

Contraceptive Devices Market

Contraceptive Devices Market: By Product Type (Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms & Sponges, Vaginal Rings, Intrauterine Devices, Sub-dermal Implants, Others), By Technology (Hormonal Contraceptives, Barrier Contraceptives), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel & NGO, Others), And Region - Global Analysis of Market Size, Share & Trends For 2019-2021 And Forecasts To 2031

Published on: May-2023
Report Code: FG HC 01510
No. of Pages: 170-350
Report Format: PDF

Product Overview

Global Contraceptive Devices Market to surpass USD 34.3 billion by 2031 from USD 18.4 billion in 2021 at a CAGR of 6.4% in the coming years, i.e., 2021-2031.

A method or equipment used to prevent pregnancy is known as birth control, sometimes known as contraception, fertility control, or anti-conception. Sterilization through vasectomy in males and tubal ligation in females, implanted birth control, and intrauterine devices are the most effective methods of birth control (IUDs). Some cultures prohibit or restrict access to birth control as it is morally, religiously, or politically objectionable to them. The phrase "birth control" is a bit of a misnomer as it does not usually include abortion.

Market Highlights

Global Contraceptive Devices Market is expected to reach a notable CAGR of 6.4% by the end of 2031

Global Contraceptive Devices Market to surpass USD 34.3 billion by 2031 from USD 18.4 billion in 2021 at a CAGR of 6.4% in the coming years, i.e., 2021-2031. Strong government promotions and programs for women's and children's health can be attributed to factors such as the increased use of contraceptive devices. Government involvement in promoting family planning and contraception, particularly in developing countries, is a crucial element driving the global contraceptive devices industry. Growing contraception awareness and the availability of effective contraception options are also key factors in country pregnancy and birth rates.

Market Analysis of Global Contraceptive Devices MarketGet More Information - Download Free Sample

Global Contraceptive Devices Market: Segments

Hormonal Contraceptives segment is predicted to lead with the highest CAGR during 2021-31

Based on Technology, the global Contraceptive Devices Market is fragmented into Hormonal Contraceptives, and Barrier Contraceptives. Hormonal contraceptives and barrier contraceptives make up the worldwide contraceptive devices market. Hormonal contraceptives have been anticipated to lead the market in terms of revenue in recent years, and this trend is expected to continue in the future due to increased preference and efficiency.

Hospital segment is expected to capture considerable growth with the highest CAGR during 2021-31

Global Contraceptive Devices Market is classified on the basis of Distribution Channel into Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel & NGO, and Others. Owing to the increased use of implantable contraceptive devices by healthcare professionals and active government backing for contraceptive distribution through government-assisted hospitals around the world, hospital pharmacies are a key source of contraceptive devices. The market for contraceptives is predicted to rise significantly in the next years due to rising demand.

Get More Information - Download Free Sample

Market Dynamics

Drivers

Growing focus on the need for family planning and avoiding unwanted pregnancy

The market is growing as people become more aware of the importance of family planning and preventing unplanned pregnancies. Furthermore, the market is driven by an increase in the use of contraceptives among young women and a rise in educational attainment. Furthermore, the rise in usage of oral tablets as a crucial technique to avoid unwanted pregnancy, as well as health risks linked with teenage pregnancies, are driving the contraceptive devices market expansion.

Rising awareness about the contraceptive products

The global contraceptive market is growing due to the high absorption rate, increased participation of reproductive women in the workforce, and increased population awareness of contraceptive products. Furthermore, rising disposable income in developing nations such as India, Africa, Brazil, and others, which leads to increased contraceptive product adoption, propels the global contraceptive devices market forward.

Restraint

Side effects associated with the Contraceptive Devices

The market's growth is projected to be hampered by contraceptive device adverse effects. In addition, increased rates of infertility are expected to stymie the expansion of the contraceptive devices market throughout the forecast period.

Global Contraceptive Devices Market:

Key Players

  • Bayer AG

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

  • Pfizer Inc.
  • Janssen Global Services, LLC
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • Mylan N.V.
  • Allergan Reckitt Benckiser Group plc
  • Veru Inc.
  • Church & Dwight Co., Inc.
  • Medisafe Distribution Inc.
  • Other Prominent Players

Global Contraceptive Devices Market: Regions

Global Contraceptive Devices Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America leads the contraceptive device industry owing to the surge in the frequency of STDs. Furthermore, throughout the projected period, an increase in the adoption rate of contraceptive devices will fuel the growth of the contraceptive devices market in the region. Due to rising awareness, Asia-Pacific is expected to see considerable growth in the contraceptive device industry. Furthermore, the rise in government initiatives is expected to fuel the growth of the contraceptive devices market in the area over the forecast period in the future years. n the time frame that has been set.

Contraceptive Devices Market: RegionsGet More Information - Download Free Sample

Impact of COVID-19 on Contraceptive Devices Market

The COVID-19 pandemic, compelled many worldwide companies in the contraceptives industry to temporarily suspend operations in order to comply with new government rules aimed at preventing the disease's spread. This suspension in operations has a direct influence on the worldwide contraceptive devices market's revenue flow. Furthermore, due to a lack of raw materials and people, the manufacturing of industrial items came to a halt. During the COVID-19 epidemic, lockdowns were imposed.

Global Contraceptive Devices Market is further segmented by region into:

  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States, Mexico, and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – France, Germany, Italy, Spain, and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, and Rest of Asia Pacific
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, South Africa and Rest of Middle East and Africa

The Global Contraceptive Devices Market report also contains analysis on:

Contraceptive Devices Market Segments:

  • By Product Type
    • Male Contraceptive Devices
    • Female Contraceptive Devices
    • Female Condoms
    • Diaphragms & Sponges
    • Vaginal Rings
    • Intrauterine Devices
    • Sub-dermal Implants
    • Others
  • By Technology
    • Hormonal Contraceptives
    • Barrier Contraceptives
  • By Distribution Channel
    • Hospital Pharmacy
    • Retail Pharmacy
    • Clinics
    • Online Channels
    • Public Channel & NGO
    • Others
  • Contraceptive Devices Market Dynamics
  • Contraceptive Devices Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

Contraceptive Devices Market Report Scope and Segmentation

Report Attribute

Details

Market size value in 2021

USD 18.4 billion

Revenue forecast in 2031

USD  34.3 billion

Growth Rate

CAGR of 6.4% from 2021 to 2031

Base year for estimation

2020

Quantitative units

Revenue in USD million and CAGR from 2021 to 2031

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product Type, Technology, Distribution Channel, and  Region

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

Key companies profiled

Bayer AG, Pfizer Inc., Janssen Global Services, LLC, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Allergan Reckitt Benckiser Group plc, Veru Inc., Church & Dwight Co., Inc., Medisafe Distribution Inc., and Other players.

 

Frequently Asked Questions (FAQ):

The Contraceptive Devices Market size was estimated at USD 18.4 billion in 2021 and is expected to reach USD 34.3 billion in 2031.

Contraception is a method of preventing pregnancy using drugs or a device. It is also known as birth control and fertility control. The devices or drugs used in contraception interfere with the normal process of sperm-ovum fertilization to prevent pregnancy.

The Hormonal Contraceptives segment accounted for the largest Contraceptive Devices Market share.

Key players in the Contraceptive Devices Market include Bayer AG, Pfizer Inc., Janssen Global Services, LLC, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Allergan Reckitt Benckiser Group plc, Veru Inc., Church & Dwight Co., Inc., Medisafe Distribution Inc., and Other players

The rising focus on the need for family planning and avoiding unwanted pregnancy is fuelling the market growth.

Select License Type

$3199

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at info@fatposglobal.com with your request

Call us

Research Assistance

US : +1 (716) 218-3733
UK : +44 (208) 1235555



Select License Type

$3199

Report accessible by 1 user only

Sample Request

Client Testimonials

FATPOS CLIENT Appriciation DURING THE PROJECT

Clients